http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2189820-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 1995-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80a44d8b03c2b4c1251a969a80e087d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67fc14824af08176bffc964132c0c3ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b4b36dcee1c0d3380994c0ec0414d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67c144bde0c37eb5284c50acebb086d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7516d41b253e83426a8a99514a5489e9 |
| publicationDate | 2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2189820-T3 |
| titleOfInvention | NEW DERIVATIVES OF ERYTHROMYCIN, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS MEDICINES. |
| abstract | THE INVENTION CONCERNS COMPOUNDS OF GENERAL FORMULA (I) IN WHICH: EITHER R1 AND R2 IDENTICAL OR DIFFERENT REPRESENT A HYDROGEN ATOM OR A HYDROCABONATED RADICAL CONTAINING UP TO 24 CARBON, SATURATED OR INSTITUTED UNDERPUTED, EVENTPROTED OR MISCELLANEOUS HETEROATOMS AND THAT EVENUALLY CARRIES ONE OR VARIOUS FUNCTIONAL GROUPS, OR WELL R1 AND R2 FORM TOGETHER WITH THE NITROGEN ATOM TO WHICH A HETEROCICLE IS CONTAINED EVENTUALLY ONE OR VARIOUS HETEROATOMES BLIND AND OXYGEN ORIGINATED AND BLIND R2 TOGETHER A RADICAL IN WHICH R''1 AND R''2 IDENTICAL OR DIFFERENT REPRESENT A HYDROGEN ATOM OR A HYDROCARBON RADICAL CONTAINING UP TO 23 CARBON, SATURATED OR INSATURATED ATOMOS, EVENTUALLY INTERRUPTED BY ONE OR VARIOUS EVENTUALLY ONE OR VARIOUS FUNCTIONAL GROUPS AND Z REPRESENTS A HYDROGEN ATOM OR THE REST OF A CARBOXYL ACID CONTAINING UP TO 18 CARBON ATOMS, AS WELL AS AD SALTS ITION WITH THE ACIDS OF THE FORMULA COMPOUNDS (I). THE FORMULA COMPOUNDS (I) PRESENT INTERESTING ANTIBIOTIC PROPERTIES. |
| priorityDate | 1994-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.